Management of Inflammatory Bowel Disease (IBD): A Still Debated Issue
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (30 November 2021)
Special Issue Editors
Interests: general and minimally invasive surgery; coloproctological surgery and inflammatory bowel diseases; upper GI and bariatric surgery; surgical oncology
Special Issues, Collections and Topics in MDPI journals
Interests: oncologic surgery; minimally invasive surgery; abdominal surgery; inflammatory bowel disease surgery; abdominal wall surgery; colorectal surgery; gastric surgery; bile duct stones; cholecystectomy; UGI surgery; breast surgery, trauma and emergency surgery; surgery in low incomes and war settings
Special Issues, Collections and Topics in MDPI journals
Interests: abdominal surgery; minimally invasive surgery; oncologic surgery; abdominal wall surgery; proctology; colorectal surgery; inflammatory bowel disease surgery; pelvic floor disease; gastric surgery; cholecystectomy; thyroid surgery
Special Issues, Collections and Topics in MDPI journals
2. Department of General Surgery, University of Rome “Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy
Interests: abdominal surgery; minimally invasive surgery; oncologic surgery; abdominal wall surgery; proctology; colorectal surgery; inflammatory bowel disease surgery; pelvic floor disease; gastric surgery; cholecystectomy; thyroid surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inflammatory bowel diseases (IBD), mainly represented by ulcerative colitis (UC) and Crohn’s disease (CD), have always represented a challenge for clinicians, surgeons and scientists.
Many efforts have been made in order to define the pathogenesis of the disease and to establish the best conservative and surgical treatment options. The advancement of molecular and clinical research plays a role in our understanding of IBD. The etiology is still unclear, but genetic, immunological, and environmental factors seem to be involved in the pathogenesis of the disease.
Recent advances have a substantial impact on the therapeutic paradigm: to date, the aim of medical treatment is not only to control and face symptoms, but to decrease inflammation, to induce mucosal healing and alter the natural course of the disease. Early surgery is gradually gaining a more important role in the multidisciplinary management of IBD, rather than being only a last resort therapy. Tailored surgical approaches are proven to be a good alternative in terms of effectiveness, quality of life and costs as first-line therapy or as part of combination therapy with biologicals for certain conditions. The particular course of the IBDs dictates, when necessary, a surgical treatment by dedicated surgeons. As well, the indication for surgery should be discussed in a multidisciplinary team. Moreover, even given the benign nature of this condition, the possible evolution of a malignant disease always has to be considered, for both the indication of surgery and the type of surgery to perform. Another key point of the IBD is the wide possibility of available surgical procedures to treat this condition, although this is difficult to standardize, and there is a high postoperative complication rate reported in literature.
This Special Issue offers an overview of the most recent advancements in the management of these patients.
Dr. Andrea Balla
Dr. Rosa Scaramuzzo
Dr. Anna Guida
Dr. Federica Saraceno
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease (IBD)
- ulcerative colitis (UC)
- Crohn’s disease (CD)
- surveillance
- diagnosis
- surgical management
- postoperative complications
- cancer
